Pembrolizumab-induced myasthenia gravis in a patient with thymic carcinoma: A case report and review of the literature
Pembrolizumab is an immune checkpoint inhibitor. Most cases of myasthenia gravis (MG) reported with the use of immune checkpoint inhibitors have been in melanomas, and small and non-small cell lung carcinoma, but there are no reported cases in thymic epithelial carcinoma. A 57-year-old male with thy...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| coleção: | Neurological Sciences and Neurophysiology |
| Assuntos: | |
| Acesso em linha: | http://www.nsnjournal.org/article.asp?issn=2636-865X;year=2021;volume=38;issue=1;spage=73;epage=78;aulast=Aykac |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|